Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Soc Sci Med. 2022 Mar 4;298:114866. doi: 10.1016/j.socscimed.2022.114866

Table 3.

Prevalence ratios of associations between lifetime discrimination and high-risk allostatic load score

Outcome Category Model 1a Model 2b Model 3c
SNS None (ref)
One to two
Three or more
--
1.02 (0.89, 1.16)
0.77 (0.65, 0.91)
--
1.05 (0.92, 1.20)
0.85 (0.71, 1.01)
--
1.03 (0.90, 1.17)
0.82 (0.69, 0.98)
PNS None (ref)
One to two
Three or more
--
0.88 (0.76, 1.02)
0.91 (0.76, 1.07)
--
0.95 (0.82, 1.10)
1.07 (0.89, 1.27)
--
0.95 (0.82, 1.10)
1.06 (0.88, 1.26)
HPA Axis None (ref)
One to two
Three or more
--
0.93 (0.82, 1.05)
0.90 (0.78, 1.04)
--
0.98 (0.87, 1.10)
1.00 (0.86, 1.16)
--
0.98 (0.87, 1.11)
1.01 (0.87, 1.17)
Inflammation None (ref)
One to two
Three or more
--
1.19 (1.07, 1.32)
1.48 (1.32, 1.65)
--
1.15 (1.04, 1.27)
1.29 (1.15, 1.44)
--
1.13 (1.02, 1.25)
1.28 (1.14, 1.43)
Cardiovascular None (ref)
One to two
Three or more
--
1.05 (0.93, 1.18)
1.15 (1.01, 1.32)
--
1.08 (0.96, 1.21)
1.17 (1.02, 1.34)
--
1.08 (0.96, 1.22)
1.17 (1.02, 1.34)
Metabolic
Glucose
None (ref)
One to two
Three or more
--
1.37 (1.20, 1.56)
1.54 (1.33, 1.77)
--
1.36 (1.20, 1.55)
1.42 (1.22, 1.65)
--
1.35 (1.19, 1.54)
1.45 (1.24, 1.68)
Metabolic
Lipids
None (ref)
One to two
Three or more
--
1.09 (0.99, 1.20)
1.16 (1.04, 1.30)
--
1.14 (1.04, 1.26)
1.29 (1.15, 1.44)
--
1.13 (1.03, 1.24)
1.28 (1.15, 1.43)
Overall AL
Score
None (ref)
One to two
Three or more
--
1.06 (1.00, 1.13)
1.11 (1.03, 1.19)
--
1.09 (1.03, 1.16)
1.14 (1.07, 1.22)
--
1.08 (1.02, 1.15)
1.14 (1.06, 1.22)
a:

unadjusted

b:

adjusted for race (ref=Black), age, sex (ref=Female), and wave

c:

adjusted for b and employment status, educational attainment, smoking and drinking status, and income